Neuphoria Therapeutics (NEUP) Change in Cash (2023 - 2026)
Neuphoria Therapeutics (NEUP) reported Change in Cash of -$2.8 million for Q1 2026, down 122.12% year-over-year from $12.7 million in Q1 2025, and down 132.97% on a QoQ basis from $8.5 million in Q4 2025.
Neuphoria Therapeutics (NEUP) has 4 years of Change in Cash data on file, last reported at -$2.8 million in Q1 2026.
- Quarterly Change in Cash fell 122.12% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 73.06% YoY) and the FY2025 annual result came in at $1.6 million, up 217.18% from the prior year.
- Change in Cash retreated to -$2.8 million in Q1 2026 per NEUP's latest filing, from $8.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $12.7 million in Q1 2025 and bottomed at -$4.5 million in Q3 2024.
- The 4-year median for Change in Cash is -$1.7 million (2024), against an average of $659882.8.
- The widest annual swing landed in 2024, when Change in Cash tumbled 300.16%; it then soared 833.07% in 2025.
- Tracing NEUP's Change in Cash over 4 years: stood at $1.9 million in 2023, then tumbled by 300.16% to -$3.7 million in 2024, then jumped by 327.47% to $8.5 million in 2025, then slumped by 132.97% to -$2.8 million in 2026.
- Per Business Quant, the three latest NEUP Change in Cash figures stand at -$2.8 million (Q1 2026), $8.5 million (Q4 2025), and -$560488.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - | -2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81 Mn |
| Dec 31, 2025 | 8.52 Mn |
| Sep 30, 2025 | -560,488.00 |
| Jun 30, 2025 | -2.83 Mn |
| Mar 31, 2025 | 12.70 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Sep 30, 2024 | -4.52 Mn |
| Jun 30, 2024 | 4.18 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | -3.82 Mn |